BRIEF-Silence Therapeutics appoints chief medical officer

LONDON Wed Jan 2, 2013 3:44am EST

Related Topics

LONDON Jan 2 (Reuters) - Silence Therapeutics PLC : * Appointment of chief medical officer * appointed Michael Khan to oversee Phase II clinical trials

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.